BioLife Solutions, Inc. (BLFS)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research
View more

Current Price

as of Mar 13, 2025

$25.06

P/E Ratio

N/A

Market Cap

$1.18B

Mar 21, 2024Apr 25, 2024May 30, 2024Jul 3, 2024Aug 5, 2024Sep 6, 2024Oct 9, 2024Nov 12, 2024Dec 18, 2024Jan 27, 2025Mar 13, 2025$20.00$30.00$40.00
  • SBSI
Description
Add to research
View more

BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.

Metrics
Add to research
View more

Overview

  • HQBothell, WA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerBLFS
  • Price$25.06-4.61%

Trading Information

  • Market cap$1.18B
  • Float96.76%
  • Average Daily Volume (1m)390,638
  • Average Daily Volume (3m)306,469
  • EPS-$0.78

Company

  • Revenue$82.25M
  • Rev growth (1yr)-42.59%
  • Net income-$11.39M
  • Gross margin61.92%
  • EBITDA margin-1.99%
  • EBITDA-$1.64M
  • EV$1.12B
  • EV/Revenue13.63
  • P/EN/A
  • P/S14.04
  • P/B3.37
  • Debt/Equity8.65
Documents
Add to research
View more